What Does BCAT-IN-4 Mean?
The key stop point was the protection and tolerability of sifalimumab. Therapy-emergent adverse situations (AEs) and significant AEs (SAEs) and their severity, final result, and any romantic relationship for the study medication were being recorded with the investigator through the entire analyze. AEs have been regarded as more likely to be associa